1 February 1999 in Clinical Chemistry
Although several approaches for measuring plasma total homocysteine by HPLC have been described during the last few years (1)(2)(3)(4), none combines all the desired features for a rapid, user-friendly, and robust assay: (a) a stable, efficient, and nonhazardous reducing agent; (b) incorporation of a suitable internal standard; and (c) rapid, isocratic separation of the thiols of interest, using a mobile phase of mild pH. We have therefore modified the method of Vester and Rasmussen (5) by using tris(2-carboxyethyl)phosphine (TCEP), a newer stable, water-soluble phosphine derivative introduced by Gilfix et al. (6), as the reducing agent, cystamine as the internalnd isocratic separation of the thiols extracted from only 50 μL of pla standard, asma within 6 min.
1 August 2016 in The American Journal of Clinical Nutrition
Background: Temporal trends in the US population’s vitamin D status have been uncertain because of nonstandardized serum 25-hydroxyvitamin D [25(OH)D
1 December 2016 in The American Journal of Clinical Nutrition
Background: Folate cutoffs for risk of deficiency compared with possible deficiency were originally derived differently (experimental compared with ep
1 August 1999 in Clinical Chemistry
Background: Information on interlaboratory variation and especially on methodological differences for plasma total homocysteine is lacking. Methods: We studied 14 laboratories that used eight different method types: HPLC with electrochemical detection (HPLC-ED); HPLC with fluorescence detection (HPLC-FD) further subdivided by type of reducing/derivatizing agent; gas chromatography/mass spectrometry (GC/MS); enzyme immunoassay (EIA); and fluorescence polarization immunoassay (FPIA). Three of these laboratories used two methods. The laboratories participated in a 2-day analysis of 46 plasma samples, 4 additional plasma samples with added homocystine, and 3 plasma quality-control (QC) pools. Results were analyzed for imprecision, recovery, and methodological differences. Results: The mean among-laboratory and among-run within-laboratory imprecision (CV) was 9.3% and 5.6% for plasma samples, 8.8% and 4.9% for samples with added homocystine, and 7.6% and 4.2% for the QC pools, respectively. Difference plots showed values systematically higher than GC/MS for HPLC-ED, HPLC-FD using sodium borohydride/monobromobimane (however, for only one laboratory), and EIA, and lower values for HPLC-FD using trialkylphosphine/4-(aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole. The two HPLC-FD methods using tris(2-carboxyethyl) phosphine/ammonium 7-fluoro-2,1,3-benzoxadiazole-4-sulfonate (SBD-F) or tributyl phosphine/SBD-F, and the FPIA method showed no detectable systematic difference from GC/MS. Conclusions: Among-laboratory variations within one method can exceed among-method variations. Some of the methods tested could be used interchangeably, but there is an urgent need to improve analytical imprecision and to decrease differences among methods.
26 September 2014 in Analytical and Bioanalytical Chemistry
1 March 2017 in Advances in Nutrition
For the past 45 y, the National Center for Health Statistics at the CDC has carried out nutrition surveillance of the US population by collecting ant